Literature DB >> 912211

Inhibition by a stable analogue of adenosine triphosphate of platelet aggregation by adenosine diphosphate.

G V Born, J G Foulks.   

Abstract

1 In citrated platelet-rich plasma, freshly prepared from rabbit blood, the velocity of platelet aggregation was within limits proportional to the log of the concentration of added adenosine diphosphate (ADP). 2 Addition of either adenosine triphosphate (ATP) or its beta,y-methylene analogue inhibited aggregation similarly except that the analogue was about half as potent as ATP. beta,y-Methylene ATP also reversed the optical effects associated with the shape change of platelets very similarly to ATP itself. 3 As beta,y-methylene ATP is not a substrate for nucleoside diphosphokinase, these observations do not support the proposition that inhibition of aggregation by added ATP is due to its utilization by the nucleoside diphosphokinase of platelets.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 912211      PMCID: PMC1667631          DOI: 10.1111/j.1476-5381.1977.tb09743.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

1.  THE AGGREGATION OF BLOOD PLATELETS.

Authors:  G V BORN; M J CROSS
Journal:  J Physiol       Date:  1963-08       Impact factor: 5.182

2.  Effects of a phosphonic acid analog of adenosine triphosphate on actomyosin systems.

Authors:  C MOOS; N R ALPERT; T C MYERS
Journal:  Arch Biochem Biophys       Date:  1960-06       Impact factor: 4.013

3.  The effects of ATP on platelets: evidence against the central role of released ADP in primary aggregation.

Authors:  D E Macfarlane; D C Mills
Journal:  Blood       Date:  1975-09       Impact factor: 22.113

4.  Effects of the ATP analog 5'-adenylyl methylenediphosphonate on acid secretion in frog gastric mucosa.

Authors:  G W Kidder
Journal:  Biochim Biophys Acta       Date:  1973-03-29

5.  Interactions of nucleoside di- and triphosphates with rabbit platelets.

Authors:  M A Packham; M A Guccione; D W Perry; J F Mustard
Journal:  Am J Physiol       Date:  1974-11

6.  Binding of adenosine triphosphate to sodium and potassium ion-stimulated adenosine triphosphatase.

Authors:  C Hegyvary; R L Post
Journal:  J Biol Chem       Date:  1971-09-10       Impact factor: 5.157

7.  Effect of the rapid shape change of platelets on the transmission and scattering of light through plasma.

Authors:  F Michal; G V Born
Journal:  Nat New Biol       Date:  1971-06-16

8.  Uptake of adenosine and of adenosine diphosphate by human blood platelets.

Authors:  G V Born
Journal:  Nature       Date:  1965-06-12       Impact factor: 49.962

9.  Interaction of P--N--P and P--C--P analogs of adenosine triphosphate with heavy meromyosin, myosin, and actomyosin.

Authors:  R G Yount; D Ojala; D Babcock
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

10.  Observations on the change in shape of blood platelets brought about by adenosine diphosphate.

Authors:  G V Born
Journal:  J Physiol       Date:  1970-08       Impact factor: 5.182

  10 in total
  4 in total

Review 1.  pA2 values for antagonists of platelet activating factor on aggregation of rabbit platelets.

Authors:  S R O'Donnell; C J Barnett
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

2.  Adenosine 5-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors.

Authors:  N J Cusack; S M Hourani
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

3.  Fibrin, red cell and platelet interactions in an experimental model of thrombosis.

Authors:  J R Smith; A M White
Journal:  Br J Pharmacol       Date:  1982-09       Impact factor: 8.739

4.  Specific but noncompetitive inhibition by 2-alkylthio analogues of adenosine 5'-monophosphate and adenosine 5'-triphosphate of human platelet aggregation induced by adenosine 5'-diphosphate.

Authors:  N J Cusack; S M Hourani
Journal:  Br J Pharmacol       Date:  1982-02       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.